Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells

  1. Franco-Trepat, E.
  2. Guillán-Fresco, M.
  3. Alonso-Pérez, A.
  4. López-Fagúndez, M.
  5. Pazos-Pérez, A.
  6. Crespo-Golmar, A.
  7. Gualillo, O.
  8. Jorge-Mora, A.
  9. Bravo, S.B.
  10. Gómez, R.
Revista:
Biomedicine and Pharmacotherapy

ISSN: 1950-6007,  0753-3322

Ano de publicación: 2022

Volume: 155

Tipo: Artigo

DOI: 10.1016/J.BIOPHA.2022.113671 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus